(Q43855434)

27 November 2017

title

Nuclear localisation of CIITA is controlled by a carboxy terminal leucine-rich repeat region (English)

1 reference

27 November 2017

Michael Towey

1 reference

27 November 2017

Adrian P Kelly

series ordinal

1 reference

27 November 2017

publication date

1 January 2002

1 reference

27 November 2017

1 reference

27 November 2017

1 reference

27 November 2017

1 reference

27 November 2017

page(s)

627-634

1 reference

Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

The cAMP-dependent protein kinase site (Ser312) enhances dorsal nuclear import through facilitating nuclear localization sequence/importin interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Structural and functional diversity in the leucine-rich repeat family of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Associations and interactions between bare lymphocyte syndrome factors

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

GTP binding by class II transactivator: role in nuclear import

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Molecular pathogenesis of Bernard-Soulier syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Nuclear targeting signal recognition: a key control point in nuclear transport?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Phosphorylation regulates association of the transcription factor Pho4 with its import receptor Pse1/Kap121.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Structural diversity of leucine-rich repeat proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Nuclear transport and transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Two distinct domains within CIITA mediate self-association: involvement of the GTP-binding and leucine-rich repeat domains

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Absence of MHC class II gene expression in a patient with a single amino acid substitution in the class II transactivator protein CIITA.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

The bare lymphocyte syndrome and the regulation of MHC expression

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Switching affinities in nuclear trafficking

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Karyopherins and kissing cousins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2801%2900093-1

7 January 2021

10.1016/S0161-5890(01)00093-1

Identifiers

DOI

1 reference

27 November 2017

1 reference